Information for "News:Angiomax Monotherapy Associated with Reduced Net Adverse Clinical Events, Major Bleeding and Cardiac‐Related Death Compared to Heparin Plus a Glycoprotein IIb/IIIa Inhibition in Primary PCI: Results of HORIZONS AMI"
Jump to navigation
Jump to search
Basic information
| Display title | News:Angiomax Monotherapy Associated with Reduced Net Adverse Clinical Events, Major Bleeding and Cardiac‐Related Death Compared to Heparin Plus a Glycoprotein IIb/IIIa Inhibition in Primary PCI: Results of HORIZONS AMI |
| Default sort key | News:Angiomax Monotherapy Associated with Reduced Net Adverse Clinical Events, Major Bleeding and Cardiac‐Related Death Compared to Heparin Plus a Glycoprotein IIb/IIIa Inhibition in Primary PCI: Results of HORIZONS AMI |
| Page length (in bytes) | 0 |
| Namespace ID | 0 |
| Page ID | 0 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Disallowed |
| Number of redirects to this page | 0 |
| Number of subpages of this page | 0 (0 redirects; 0 non-redirects) |
Page protection
| Create | Allow all users (infinite) |